WHO enters new terrain in Ebola research
M Shuchman - 2014 - Can Med Assoc
M Shuchman
2014•Can Med AssocThe meeting on unproven interventions for Ebola at the World Health Organization on Sept.
4 and 5 takes the global agency into “absolutely uncharted territory,” says WHO
spokesperson, Dr. Margaret Harris.“We're actually often criticized for being incredibly slow
about saying,'Do this over that', because we demand enormous levels of evidence,” she
says. But for Ebola virus disease, there are no approved therapies, so WHO is attempting to
move investigational interventions forward, including medications, vaccines and so-called …
4 and 5 takes the global agency into “absolutely uncharted territory,” says WHO
spokesperson, Dr. Margaret Harris.“We're actually often criticized for being incredibly slow
about saying,'Do this over that', because we demand enormous levels of evidence,” she
says. But for Ebola virus disease, there are no approved therapies, so WHO is attempting to
move investigational interventions forward, including medications, vaccines and so-called …
The meeting on unproven interventions for Ebola at the World Health Organization on Sept. 4 and 5 takes the global agency into “absolutely uncharted territory,” says WHO spokesperson, Dr. Margaret Harris.
“We’re actually often criticized for being incredibly slow about saying,‘Do this over that’, because we demand enormous levels of evidence,” she says. But for Ebola virus disease, there are no approved therapies, so WHO is attempting to move investigational interventions forward, including medications, vaccines and so-called convalescent serum, made from the blood of survivors.
Can Med Assoc